Collegium Pharmaceutical, Inc SEC filings COLL

Collegium Pharmaceutical, Inc has 870 filings in SEC EDGAR's recent list, going back to Oct 20, 2003. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Collegium Pharmaceutical, Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 5, 2026 Nov 5, 2026
8-K Current report
Agreement ended
Oct 19, 2026 Oct 15, 2026
8-K Current report
Other events
Aug 13, 2026 Aug 12, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2026 Aug 6, 2026
8-K/A Amended current report Jun 30, 2026 May 12, 2026
S-8 Employee stock plan registration Jun 1, 2026 —
S-8 Employee stock plan registration Jun 1, 2026 —
8-K Current report
Shareholder vote results
May 15, 2026 May 14, 2026
8-K Current report
Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
May 12, 2026 May 12, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 7, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 7, 2026 May 14, 2026
8-K Current report
Officer or director change
Apr 7, 2026 Apr 2, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Mar 19, 2026 Mar 19, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
8-K Current report
Regulation FD disclosure
Jan 8, 2026 Jan 8, 2026
8-K Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
Dec 30, 2025 Dec 23, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2025 Aug 7, 2025
8-K Current report
Other events
Jul 7, 2025 Jul 1, 2025
S-8 POS Filing Jun 6, 2025 —
S-8 POS Filing Jun 6, 2025 —
S-8 POS Filing Jun 6, 2025 —
S-8 POS Filing Jun 6, 2025 —
S-8 POS Filing Jun 6, 2025 —
S-8 POS Filing Jun 6, 2025 —
S-8 POS Filing Jun 6, 2025 —
S-8 POS Filing Jun 6, 2025 —
S-8 POS Filing Jun 6, 2025 —
S-8 POS Filing Jun 6, 2025 —
S-8 Employee stock plan registration Jun 6, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
May 19, 2025 May 15, 2025
8-K Current report
Other events
May 12, 2025 May 12, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2025 May 8, 2025
DEFA14A Additional proxy material Mar 28, 2025 —
ARS Annual report to shareholders Mar 28, 2025 Dec 31, 2024
DEF 14A Proxy statement Mar 28, 2025 May 15, 2025
8-K Current report
Officer or director change, Other events
Mar 17, 2025 Mar 11, 2025
S-8 Employee stock plan registration Mar 6, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Feb 27, 2025 Feb 27, 2025
8-K Current report
Officer or director change
Feb 5, 2025 Feb 3, 2025
8-K Current report
Regulation FD disclosure
Jan 8, 2025 Jan 8, 2025
8-K/A Amended current report Nov 14, 2024 Sep 3, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Nov 7, 2024 Nov 6, 2024
8-K Current report
Acquisition or sale of assets, New debt, Regulation FD disclosure
Sep 4, 2024 Sep 3, 2024
S-8 Employee stock plan registration Aug 15, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 8, 2024 Aug 8, 2024
8-K Current report
Material agreement, Results of operations, New debt, Officer or director change, Regulation FD disclosure
Jul 29, 2024 Jul 28, 2024
8-K Current report
Other events
Jun 13, 2024 Jun 13, 2024
8-K Current report
Officer or director change
May 24, 2024 May 24, 2024
8-K Current report
Shareholder vote results
May 20, 2024 May 16, 2024
8-K Current report
Other events
May 13, 2024 May 13, 2024
DEFA14A Additional proxy material May 10, 2024 —
8-K Current report
Officer or director change
May 10, 2024 May 9, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 9, 2024 May 9, 2024
8-K Current report
Material agreement
Apr 29, 2024 Apr 26, 2024
8-K Current report
Other events
Apr 11, 2024 Apr 11, 2024
ARS Annual report to shareholders Apr 5, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 5, 2024 —
DEF 14A Proxy statement Apr 5, 2024 May 16, 2024
10-K Annual report Feb 22, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 22, 2024 Feb 22, 2024
8-K Current report
Regulation FD disclosure, Other events
Jan 3, 2024 Jan 1, 2024
8-K Current report
Other events
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 7, 2023 Nov 7, 2023
8-K Current report
Other events
Aug 24, 2023 Aug 24, 2023
S-8 Employee stock plan registration Aug 10, 2023 —
8-K Current report
Other events
Aug 7, 2023 Aug 7, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 3, 2023 Aug 3, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
May 19, 2023 May 18, 2023
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 4, 2023 May 4, 2023
ARS Annual report to shareholders Apr 11, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 11, 2023 —
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Feb 23, 2023 Feb 23, 2023
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Feb 13, 2023 Feb 10, 2023
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Feb 6, 2023 Feb 6, 2023
8-K Current report
Regulation FD disclosure, Other events
Jan 4, 2023 Jan 1, 2023
8-K Current report
Regulation FD disclosure, Other events
Dec 22, 2022 Dec 21, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 3, 2022 Nov 3, 2022
S-8 Employee stock plan registration Aug 11, 2022 —
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Aug 4, 2022 Aug 4, 2022
8-K Current report
Shareholder vote results
May 23, 2022 May 19, 2022
8-K/A Amended current report May 13, 2022 Mar 23, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2022 May 10, 2022
8-K Current report
Regulation FD disclosure
Apr 13, 2022 Apr 13, 2022
DEFA14A Additional proxy material Apr 6, 2022 —
DEF 14A Proxy statement Apr 6, 2022 May 19, 2022
8-K Current report
Officer or director change
Apr 6, 2022 Apr 6, 2022
8-K Current report
Regulation FD disclosure
Apr 5, 2022 Apr 5, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Officer or director change, Other events
Mar 23, 2022 Mar 22, 2022
SC TO-T/A Filing Mar 21, 2022 —
SC TO-T/A Filing Mar 11, 2022 —
SC TO-T/A Filing Mar 4, 2022 —
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
SC TO-T/A Filing Feb 22, 2022 —
SC TO-T Filing Feb 18, 2022 —
SC TO-C Filing Feb 14, 2022 —
8-K Current report
Material agreement, Regulation FD disclosure
Feb 14, 2022 Feb 14, 2022
8-K Current report
Regulation FD disclosure, Other events
Dec 28, 2021 Dec 28, 2021
8-K Current report
Exit or restructuring costs
Nov 12, 2021 Nov 12, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Officer or director change, Other events
Sep 30, 2021 Sep 24, 2021
8-K Current report
Other events
Aug 16, 2021 Aug 16, 2021
S-8 Employee stock plan registration Aug 12, 2021 —
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Regulation FD disclosure
Jun 2, 2021 Jun 2, 2021
8-K Current report
Officer or director change, Shareholder vote results
May 24, 2021 May 20, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
8-K Current report
Results of operations, Officer or director change
May 6, 2021 May 6, 2021
DEFA14A Additional proxy material Apr 7, 2021 —
DEF 14A Proxy statement Apr 7, 2021 May 20, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Regulation FD disclosure
Jan 6, 2021 Jan 6, 2021
8-K Current report
Officer or director change
Dec 30, 2020 Dec 27, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Material agreement, Other events
Sep 30, 2020 Sep 29, 2020
8-K Current report
Officer or director change, Other events
Sep 25, 2020 Sep 24, 2020
S-8 Employee stock plan registration Aug 13, 2020 —
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 5, 2020 Aug 5, 2020
8-K Current report
Officer or director change
Jul 9, 2020 Jul 8, 2020
8-K Current report
Shareholder vote results
May 22, 2020 May 20, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Apr 9, 2020 —
DEF 14A Proxy statement Apr 9, 2020 May 20, 2020
EFFECT Filing Mar 30, 2020 —
CORRESP Letter to the SEC Mar 27, 2020 —
PRE 14A Preliminary proxy statement Mar 25, 2020 May 20, 2020
UPLOAD Letter from the SEC Mar 23, 2020 —
S-3 Shelf registration Mar 16, 2020 —
10-K Annual report Feb 27, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 27, 2020 Feb 27, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, New debt, Officer or director change, Regulation FD disclosure
Feb 13, 2020 Feb 10, 2020
424B5 Prospectus supplement Feb 11, 2020 —
FWP Free writing prospectus Feb 11, 2020 —
305B2 Filing Feb 11, 2020 —
424B5 Prospectus supplement Feb 10, 2020 —
8-K Current report
Material agreement, New debt
Feb 10, 2020 Feb 6, 2020
8-K Current report
Regulation FD disclosure
Feb 6, 2020 Feb 6, 2020
8-K Current report
Regulation FD disclosure
Jan 7, 2020 Jan 7, 2020
EFFECT Filing Nov 6, 2019 —
10-Q Quarterly report Nov 6, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 6, 2019 Nov 6, 2019
CORRESP Letter to the SEC Nov 1, 2019 —
UPLOAD Letter from the SEC Oct 31, 2019 —
S-3 Shelf registration Oct 25, 2019 —
S-8 Employee stock plan registration Aug 7, 2019 —
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
10-Q Quarterly report May 8, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 8, 2019 May 8, 2019
8-K Current report
Shareholder vote results
Apr 30, 2019 Apr 25, 2019
DEFA14A Additional proxy material Mar 15, 2019 —
DEF 14A Proxy statement Mar 15, 2019 Apr 25, 2019
10-K Annual report Feb 27, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 27, 2019 Feb 27, 2019
8-K Current report
Regulation FD disclosure
Jan 7, 2019 Jan 7, 2019
D Filing Nov 13, 2018 —
10-Q Quarterly report Nov 8, 2018 Sep 30, 2018
8-K Current report
Material agreement, Results of operations, Unregistered share sale
Nov 8, 2018 Nov 8, 2018
10-Q Quarterly report Aug 8, 2018 Jun 30, 2018
8-K Current report
Results of operations
Aug 8, 2018 Aug 8, 2018
S-8 Employee stock plan registration Jun 7, 2018 —
8-K Current report
Officer or director change, Other events
Jun 4, 2018 Jun 4, 2018
8-K Current report
Shareholder vote results
May 25, 2018 May 24, 2018
10-Q Quarterly report May 9, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 9, 2018 May 9, 2018
CT ORDER Filing Apr 18, 2018 —
DEFA14A Additional proxy material Apr 13, 2018 —
DEF 14A Proxy statement Apr 13, 2018 May 24, 2018
10-K Annual report Mar 7, 2018 Dec 31, 2017
8-K Current report
Results of operations
Mar 7, 2018 Mar 7, 2018
8-K Current report
Other events
Feb 22, 2018 Feb 22, 2018
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Jan 10, 2018 Jan 9, 2018
8-K Current report
Agreement ended
Dec 14, 2017 Dec 8, 2017
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Dec 4, 2017 Dec 4, 2017

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
COLL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
VA
Headquarters
Stoughton, MA
SEC filer status
Large accelerated filer
SEC CIK
1267565
Former names
COLLEGIUM PHARMACEUTICAL INC (until Mar 3, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.